AllSci News
CalciMedica pivots toward pulmonary hypertension with USD 49m financing round
La Jolla, California-based CalciMedica, Inc. (Nasdaq: CALC) announced a private placement of up to approximately USD 49 million to pivot the company's...
MoonLake boosts public offering to USD 200m for sonelokimab
Switzerland-based MoonLake Immunotherapeutics (Nasdaq: MLTX) announced the pricing of an upsized underwritten public offering of Class A ordinary shares and...
uniQure upsizes public offering to USD 225m
Lexington, Massachusetts-based uniQure N.V. (Nasdaq: QURE) announced the pricing of an upsized underwritten public offering of ordinary shares, raising USD...
AECOM investigates novel protein-RNA interaction to block and lock HIV-1 latency
Albert Einstein College of Medicine has received a USD 3.2 million NIH R01 grant from the National Institute of Allergy and Infectious Diseases to...
Yale investigates immune mechanisms driving celiac disease to find new therapies and biomarkers
Yale University has received a USD 2.3 million NIAID P01 program project grant to investigate the immunopathogenesis of celiac disease, with a dual focus on...
Tulane Uni investigates CD4+ T cell immunity to improve pneumonia vaccines
Tulane University has received a USD 1.09 million NIH R35 award from the National Heart, Lung, and Blood Institute to investigate CD4+ T cell immunity in...
Trimtech raises USD 47m for TRIM21-targeted protein degradation in neurodegeneration
UK-based TRIMTECH Therapeutics has closed an additional USD 14 million in seed funding, bringing its total seed round to USD 47 million (£35 million), as...
Rapalogix secures USD 20m to advance TORC1-targeting skincare and prescription dermatology pipeline
Carlsbad, California-based Rapalogix Health, a biotechnology company developing TORC1-targeting therapeutics and professional skincare products for skin...
Ollin secures USD 330m to advance VEGF/Ang2 BsAb after beating Vabysmo head-to-head
Austin, Texas-based Ollin Biosciences, Inc. has closed an oversubscribed USD 330 million Series B financing round to fund global Phase III development of...
HHS launches Operation Trialblazer to reverse offshoring of early-phase clinical research
Category: Clinical Trial Reform | Regulatory Body: HHS | Geography: United States | Instrument: Initiative launch
Abu Dhabi opens gateway to California’s life sciences ecosystem
The Department of Health – Abu Dhabi (DoH) and Biocom California announced a strategic memorandum of understanding establishing a formal gateway between…
Lilly expands Abbisko partnership with multi-target deal worth up to USD 1.9b
Shanghai-based Abbisko Therapeutics Co., Ltd. (HKEX: 02256.HK) and Eli Lilly and Company have announced a multi-target research collaboration and license agreement under…
Definium secures USD 700m in upsized offering for psychedelic pipeline
New York-based Definium Therapeutics, Inc. (Nasdaq: DFTX) announced the pricing of an upsized underwritten public offering of common shares, raising...
Definium's LSD formulation becomes first psychedelic to beat placebo in Phase III depression trial
New York-based Definium Therapeutics (Nasdaq: DFTX) reported positive topline results from the Emerge Phase III trial of DT120 (lysergide) orally...
Merck KGaA, Versant launch Saturnus Bio in USD 50m rare cardiology venture
Saturnus Bio, a precision cardiology company founded by Versant Ventures, has launched with USD 50 million in upfront funding from Merck as part of a...
The AllSci Brief
Free, systematic R&D and deal news. Daily.